CD40LG and rheumatoid arthritis: Furthermore, patients who are multiplex-positive but anti- CCP-2-negative differ from anti- CCP-2-positive RA patients with regard to ACPA risk factors (HLA-SE and smoking), the presence of IgM-RF and clinical parameters (UA to RA progression and joint destruction), but do not differ from anti-CCP-2-negative patients.